The story appears on

Page A7

July 2, 2020

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Metro

Boost for medical research institutes

The first drug manufacturing license for medical research institutes in China was issued by Shanghai authorities yesterday, lifting the restrictions imposed on such drug research organizations from participating in medicine bidding and procurement.

Some provinces require drug research institutes to obtain the license before they are allowed to participate in bidding and procurement, leaving them unable to enjoy some preferential policies, the Shanghai Drug Administration said.

The first license was issued to Anbison Lab.

“The reform will stimulate the innovation vitality of biomedicine companies,” said Zhang Qing, deputy director of the administration.

Applications for drug manufacturing license from nine drug research institutes in Shanghai are being reviewed, according to the administration.


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend